Jcm Ho
- Oncology top 1%
- Lung Cancer Research Studies 17
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 47
- Cystic Fibrosis Research Advances 19
- Lung Cancer Diagnosis and Treatment 18
- Neonatal Respiratory Health Research 16
- Chronic Obstructive Pulmonary Disease (COPD) Research 16
- Respiratory Support and Mechanisms 13
- Otorhinolaryngology top 2%
- Cancer Research top 2%
- Infectious Diseases top 2%
-
- Respiratory viral infections research 14
- Co-authors
- G.C. OoiMing‐Sound TsaoKenneth W. TsangMsm IpSze Kwan LamWah Kit LamBing LamChunyan Zheng
- Partner nations
- Hong KongChinaUnited States
In The Last Decade
Jcm Ho
262 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Oncology 2.2k
- Pulmonary and Respiratory Medicine 2.5k
- Otorhinolaryngology 225
- Cancer Research 725
- Infectious Diseases 624
Countries citing papers authored by Jcm Ho
This map shows the geographic impact of Jcm Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jcm Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jcm Ho more than expected).
Fields of papers citing papers by Jcm Ho
This network shows the impact of papers produced by Jcm Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jcm Ho. The network helps show where Jcm Ho may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jcm Ho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 16 | |
| 7 | 2020 | 72 | |
| 8 | 2020 | 8 | |
| 9 | 2020 | 2 | |
| 10 | 2013 | 7 | |
| 11 | Mutational status of epidermal growth factor receptor is the only predictor of clinical response to gefitinib treatment in non-small cell lung cancer | 2006 | 1 |
| 12 | 2003 | 160 | |
| 13 | 2003 | 19 | |
| 14 | 2001 | 222 | |
| 15 | 2000 | 8 | |
| 16 | 2000 | 20 | |
| 17 | Birthplace and yield of nipple aspirate fluid in Chinese women. | 1998 | 10 |
| 18 | Results of a randomised, double-blind placebo controlled phase III study of filgrastim in remission induction and early consolidation therapy for adults with de-novo acute myeloid leukemia | 1995 | 12 |
| 19 | Development of HTS Wires and Tapes | 1992 | 1 |
| 20 | 1991 | 8 |
About Jcm Ho
Jcm Ho is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology, having authored 278 papers that have together received 7.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (47 papers), Cystic Fibrosis Research Advances (19 papers), Lung Cancer Diagnosis and Treatment (18 papers), Lung Cancer Research Studies (17 papers), Neonatal Respiratory Health Research (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Respiratory viral infections research (14 papers) and Respiratory Support and Mechanisms (13 papers). The work is most often cited by research in Oncology (2.2k citations), Pulmonary and Respiratory Medicine (2.5k citations) and Otorhinolaryngology (225 citations). Jcm Ho has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include G.C. Ooi, Ming‐Sound Tsao, Kenneth W. Tsang, Msm Ip, Sze Kwan Lam, Wah Kit Lam, Bing Lam, Chunyan Zheng, Jcw Mak and K. Tsang. Their work appears in journals such as Lung Cancer, Respirology, Journal of Thoracic Oncology, Journal of Clinical Oncology and Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.